Peripheral Arterial Disease in Patients Presenting with Acute Coronary Syndrome in Six Middle Eastern Countries

Table 2

Management of patients with acute coronary syndrome.

	No-PAD	PAD	𝑃 value
On admission medications
Thrombolysis, 𝑛 (%)	1494 (58)	24 (51)	0.34
Aspirin, 𝑛 (%)	6391(98)	172 (97)	0.49
Clopidogrel, 𝑛 (%)	3499 (54)	106 (60)	0.09
Heparin, 𝑛 (%)	3093 (48)	67 (38)	0.01
LMW Heparin, 𝑛 (%)	3073 (47)	98 (55)	0.03
Gp IIb/IIIa inhibitor, 𝑛 (%)	677 (10)	23 (13)	0.26
β-Blocker, 𝑛 (%)	4277 (66)	84 (48)	0.001
ACE/ARB, 𝑛 (%)	4498 (69)	120 (68)	0.74
Coronary angiography (%)	1217 (19)	33 (19)	0.99
PCI, 𝑛 (%)	273 (19.14.2)	7 (19.94)	0.88
Discharge medications
Aspirin, 𝑛 (%)	6155 (95)	150 (85)	0.001
Clopidogrel, 𝑛 (%)	3204 (49)	101 (57)	0.03
Statin, 𝑛 (%)	5264 (81)	156 (88)	0.01
ACE/ARB, 𝑛 (%)	4950 (76)	132 (75)	0.66
β-Blocker, 𝑛 (%)	4939 (76)	107 (61)	0.001
Diuretics, 𝑛 (%)	4561(70)	134 (76)	0.11